Pharmaceutical composition for treating benign prostatic hyperplasia and preparation thereof

By using a combination of Astragalus membranaceus, American cockroach, Aconitum carmichaelii, Eupolyphaga sinensis, Curcuma longa, and Glycyrrhiza uralensis to make pills or powders, the problem of the difficulty in quickly improving lower urinary tract symptoms of benign prostatic hyperplasia and shrinking the gland in existing technologies has been solved, achieving safe, rapid and low-cost treatment results.

CN121371098APending Publication Date: 2026-01-23JINAN KANGZHONG PHARMA TECH DEV
0 Cites 0 Cited by

Patent Information

Application Number
CN202511637043.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-11-10
Publication Date
2026-01-23

AI Technical Summary

Technical Problem

Current treatments for benign prostatic hyperplasia (BPH) are unlikely to simultaneously and quickly improve lower urinary tract symptoms and reduce prostate volume, and they also have issues with side effects or high costs.

Method used

A combination of herbs including Astragalus membranaceus, American cockroach, Aconitum carmichaelii, Eupolyphaga sinensis, Curcuma longa, and Glycyrrhiza uralensis is prepared into pills or powders. By invigorating qi and tonifying the kidneys, promoting blood circulation and removing blood stasis, it can improve lower urinary tract symptoms and reduce prostate volume.

Benefits of technology

It significantly improves lower urinary tract symptoms and reduces prostate volume in a short period of time. It is safe, inexpensive, has no side effects like those of Western medicine, takes effect quickly, and its effect is close to that of alpha-receptor blockers. Moreover, it reduces prostate volume faster than finasteride.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to a pharmaceutical composition for treating benign prostatic hyperplasia and a preparation thereof, and is characterized in that the pharmaceutical composition is prepared from the following raw material medicines in parts by weight: 4.0-4.7 parts of astragalus membranaceus, 3.0-3.8 parts of periplaneta americana, 2-3 parts of radix aconiti carmichaeli, 2-3 parts of ground beetle, 1.4-1.9 parts of turmeric and 0.37-0.95 part of liquorice, and the raw material medicines are prepared into powder or pills. The pharmaceutical composition and the preparation thereof have the advantages of improvement of lower urinary tract symptoms caused by benign prostatic hyperplasia, fast effect taking, short-term reduction of the volume of hyperplasia prostate, small dosage and low cost.
Need to check novelty before this filing date? Find Prior Art